{"url_path":"/sec/pali/8-k/2026-06-11/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 **","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-11","source_url":"https://www.sec.gov/Archives/edgar/data/1357459/0001493152-26-028322-index.html","accession_number":"0001493152-26-028322","cik":"0001357459","ticker":"PALI","issuer_name":"PALISADE BIO, INC.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1357459/0001493152-26-028322-index.html","primary_entity_key":"0001357459","primary_entity_name":"PALISADE BIO, INC."},"word_count":136,"has_tables":true,"body_markdown":"**Item\n9.01**\n**Financial\nStatement and Exhibits**\n\n \n\n(d) Exhibits\n\n \n\n**Exhibit No.****Description**\n\n3.1 [Certificate of Amendment to the Amended and Restated Certificate of Incorporation of Palisade Bio, Inc.](ex3-1.htm)\n\n10.1 [Form of Indemnity Agreement (Incorporated by reference from Exhibit 10.03 to the Company’s Current Report on Form 8-K, filed with the SEC on December 18, 2018)](https://www.sec.gov/Archives/edgar/data/1357459/000117184318008473/exh_1003.htm)\n\n10.2 [Amended and Restated Palisade Bio, Inc. 2021 Equity Incentive Plan](ex10-2.htm)\n\n10.3 [Amended and Restated Palisade Bio, Inc. 2021 Employee Stock Purchase Plan](ex10-3.htm)\n\n104 Cover Page Interactive Data File (formatted as Inline XBRL)\n\n \n\n \n\n \n\n \n\n**SIGNATURES**\n\n \n\nPursuant\nto the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report on Form 8-K to be signed on its\nbehalf by the undersigned hereunto duly authorized.\n\n \n\nDate:\nJune 11, 2026\nPalisade\nBio, Inc.\n\n \n \n \n\n \nBy:\n*/s/\nJ.D. Finley*\n\n \n \nJ.D.\nFinley\n\n \n \nChief\nExecutive Officer"}